EC-Logo-2018_TM_CMYK.jpg
electroCore Engages FNK IR to Execute Expanded Investor Relations Program
September 24, 2024 08:00 ET | electroCore, Inc.
ROCKAWAY, N.J., Sept. 24, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it has engaged FNK IR, an...
Metris Logo_Blue Logo Center Roger O'Dell.png
Metris Global Selected to Provide U.S. Coast Guard Personnel with Mission-Critical Training and Analysis Support Services
September 19, 2024 15:45 ET | Metris Global
First time TASS has been re-awarded to an incumbentFive-year agreement, from 2024 through 2029Supports Coast Guardsmen during their entire time of service ORLANDO, Fla., Sept. 19, 2024 (GLOBE...
EC-Logo-2018_TM_CMYK.jpg
Study Suggests Non-invasive Vagus Nerve Stimulation (nVNS) is effective in accelerating United States Air Force Pilot Training
September 10, 2024 08:00 ET | electroCore, Inc.
ROCKAWAY, N.J., Sept. 10, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that the Air Force Research...
EC-Logo-2018_TM_CMYK.jpg
electroCore Announces Second Quarter 2024 Financial Results
August 07, 2024 16:01 ET | electroCore, Inc.
Seventh consecutive record quarterly net sales of $6.1 million, an increase of 73% over second quarter 2023  Company to host a conference call and webcast today, August 7, 2024 at 4:30 PM EST ...
EC-Logo-2018_TM_CMYK.jpg
Non-invasive Vagus Nerve Stimulation (nVNS) is effective at accelerating foreign language learning
August 01, 2024 08:00 ET | electroCore, Inc.
ROCKAWAY, N.J., Aug. 01, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that the Air Force Research...
EC-Logo-2018_TM_CMYK.jpg
electroCore to Announce Second Quarter June 30, 2024 Financial Results on Wednesday, August 7, 2024
July 31, 2024 08:00 ET | electroCore, Inc.
ROCKAWAY, N.J., July 31, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that it will report financial...
TAC-STIM
electroCore Announces the Commercial Launch of TAC-STIM™
June 25, 2024 08:00 ET | electroCore, Inc.
ROCKAWAY, N.J., June 25, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, is thrilled to announce the Commercial Off the...
EC-Logo-2018_TM_CMYK.jpg
electroCore to Join Russell Microcap® Index
June 11, 2024 08:00 ET | electroCore, Inc.
ROCKAWAY, N.J., June 11, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that its stock is on the...
EC-Logo-2018_TM_CMYK.jpg
electroCore, Inc. Announces Closing of $9.3 Million Registered Direct Offering and Concurrent Private Placements Priced At Market Under Nasdaq Rules
June 06, 2024 08:00 ET | electroCore, Inc.
ROCKAWAY, N.J., June 06, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR) (“electroCore” or the “Company”), a commercial-stage bioelectronic medicine and wellness company, today announced...
EC-Logo-2018_TM_CMYK.jpg
electroCore, Inc. Announces $9.3 Million Registered Direct Offering and Concurrent Private Placements Priced At Market Under Nasdaq Rules
June 03, 2024 08:30 ET | electroCore, Inc.
ROCKAWAY, N.J., June 03, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR) (“electroCore” or the “Company”), a commercial-stage bioelectronic medicine and wellness company, today announced...